BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3846593)

  • 1. Staphylocoagulase-binding region in human prothrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Jan; 97(1):325-31. PubMed ID: 3846593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in enzymatic properties between "staphylothrombin" and free alpha-thrombin.
    Kawabata S; Morita T; Miyata T; Kaida S; Igarashi H; Iwanaga S
    Ann N Y Acad Sci; 1986; 485():27-40. PubMed ID: 3551730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Dec; 98(6):1603-14. PubMed ID: 4093448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of staphylocoagulase chymotryptic fragment. Localization of the procoagulant- and prothrombin-binding domain of this protein.
    Kawabata S; Morita T; Miyata T; Iwanaga S; Igarashi H
    J Biol Chem; 1986 Jan; 261(3):1427-33. PubMed ID: 3944093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase.
    Hemker HC; Bas BM; Muller AD
    Biochim Biophys Acta; 1975 Jan; 379(1):180-8. PubMed ID: 1115793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino acid sequence of the procoagulant- and prothrombin-binding domain isolated from staphylocoagulase.
    Kawabata S; Miyata T; Morita T; Miyata T; Iwanaga S; Igarashi H
    J Biol Chem; 1986 Jan; 261(2):527-31. PubMed ID: 3941089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human prothrombin by stoichiometric levels of staphylocoagulase.
    Hendrix H; Lindhout T; Mertens K; Engels W; Hemker HC
    J Biol Chem; 1983 Mar; 258(6):3637-44. PubMed ID: 6833222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
    Liu LW; Ye J; Johnson AE; Esmon CT
    J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation.
    Friedrich R; Panizzi P; Fuentes-Prior P; Richter K; Verhamme I; Anderson PJ; Kawabata S; Huber R; Bode W; Bock PE
    Nature; 2003 Oct; 425(6957):535-9. PubMed ID: 14523451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of human thrombin I fragment, prethrombin I, and alpha-thrombin with tissue thromboplastin].
    Timerbaev VN; Zubairov DM; Kiselev SV; Kirshin SV; Soboleva IV
    Biokhimiia; 1992 Jan; 57(1):77-90. PubMed ID: 1391207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates.
    Morita T; Iwanaga S; Suzuki T
    J Biochem; 1976 May; 79(5):1089-108. PubMed ID: 956136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin.
    Petrovan RJ; Govers-Riemslag JW; Nowak G; Hemker HC; Tans G; Rosing J
    Biochemistry; 1998 Feb; 37(5):1185-91. PubMed ID: 9477942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity and affinity of the N-terminal residues in staphylocoagulase in binding to prothrombin.
    Maddur AA; Kroh HK; Aschenbrenner ME; Gibson BHY; Panizzi P; Sheehan JH; Meiler J; Bock PE; Verhamme IM
    J Biol Chem; 2020 Apr; 295(17):5614-5625. PubMed ID: 32156702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation.
    Friedrich R; Panizzi P; Kawabata S; Bode W; Bock PE; Fuentes-Prior P
    J Biol Chem; 2006 Jan; 281(2):1188-95. PubMed ID: 16230338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-sepharose interaction with prothrombin, prethrombin 1, prethrombin 2 and thrombin.
    Kaczmarek E; Kaminski M; McDonagh J
    Biochim Biophys Acta; 1987 Aug; 914(3):275-82. PubMed ID: 3620475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin fragment 1 X 2 X 3, a major product of prothrombin activation in human plasma.
    Rabiet MJ; Blashill A; Furie B; Furie BC
    J Biol Chem; 1986 Oct; 261(28):13210-5. PubMed ID: 3759958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their γ-carboxyglutamic acid (Gla) domain.
    Itoh S; Yokoyama R; Kamoshida G; Fujiwara T; Okada H; Takii T; Tsuji T; Fujii S; Hashizume H; Onozaki K
    J Biol Chem; 2013 Jul; 288(30):21569-80. PubMed ID: 23754290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions.
    Panizzi P; Friedrich R; Fuentes-Prior P; Kroh HK; Briggs J; Tans G; Bode W; Bock PE
    J Biol Chem; 2006 Jan; 281(2):1169-78. PubMed ID: 16230340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.